| Hepatocyte autotaxin expression promotes liver fibrosis and cancer E Kaffe, A Katsifa, N Xylourgidis, I Ninou, M Zannikou, V Harokopos, ... Hepatology 65 (4), 1369-1383, 2017 | 160 | 2017 |
| Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ... Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019 | 116 | 2019 |
| Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 109 | 2021 |
| STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma P Zhang, A Rashidi, J Zhao, C Silvers, H Wang, B Castro, A Ellingwood, ... Nature communications 14 (1), 1610, 2023 | 46 | 2023 |
| Mesenchymal stem cells successfully deliver oncolytic virotherapy to diffuse intrinsic pontine glioma MI Chastkofsky, KC Pituch, H Katagi, M Zannikou, L Ilut, T Xiao, Y Han, ... Clinical Cancer Research 27 (6), 1766-1777, 2021 | 46 | 2021 |
| Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs MV Babak, KR Chong, P Rapta, M Zannikou, HM Tang, L Reichert, ... Angewandte Chemie International Edition 60 (24), 13405-13413, 2021 | 43 | 2021 |
| Protein tyrosine phosphatase-1B inhibition disrupts IL13Rα2-promoted invasion and metastasis in cancer cells RA Bartolomé, Á Martín-Regalado, M Jaén, M Zannikou, P Zhang, ... Cancers 12 (2), 500, 2020 | 32 | 2020 |
| Ribosomal protein S11 influences glioma response to TOP2 poisons CU Awah, L Chen, M Bansal, A Mahajan, J Winter, M Lad, L Warnke, ... Oncogene 39 (27), 5068-5081, 2020 | 23 | 2020 |
| Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity KC Pituch, M Zannikou, L Ilut, T Xiao, M Chastkofsky, M Sukhanova, ... Proceedings of the National Academy of Sciences 118 (9), e2015800118, 2021 | 20 | 2021 |
| MAP3K8 Regulates Cox-2–Mediated Prostaglandin E2 Production in the Lung and Suppresses Pulmonary Inflammation and Fibrosis M Zannikou, I Barbayianni, D Fanidis, T Grigorakaki, E Vlachopoulou, ... The Journal of Immunology 206 (3), 607-620, 2021 | 20 | 2021 |
| DNA–histone complexes as ligands amplify cell penetration and nuclear targeting of anti‐DNA antibodies via energy‐independent mechanisms M Zannikou, S Bellou, P Eliades, A Hatzioannou, MD Mantzaris, ... Immunology 147 (1), 73-81, 2016 | 18 | 2016 |
| IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM M Zannikou, JT Duffy, RN Levine, M Seblani, Q Liu, A Presser, VA Arrieta, ... Journal for immunotherapy of cancer 11 (2), 2023 | 17 | 2023 |
| Liposomal extravasation and accumulation in tumors as studied by fluorescence microscopy and imaging depend on the fluorescent label G Wang, M Zannikou, L Lofchy, Y Li, H Gaikwad, IV Balyasnikova, ... ACS nano 15 (7), 11880-11890, 2021 | 15 | 2021 |
| Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors SE Fenton, M Zannikou, L Ilut, M Fischietti, C Ji, CV Oku, CM Horvath, ... Molecular Cancer Research 21 (4), 332-344, 2023 | 6 | 2023 |
| Bi-specific killer cell engager enhances nk cell activity against interleukin-13 receptor alpha-2 positive gliomas KD Pawlowski, JT Duffy, A Tiwari, M Zannikou, IV Balyasnikova Cells 12 (13), 1716, 2023 | 4 | 2023 |
| Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors IV Balyasnikova, M Zannikou, G Wang, Y Li, JT Duffy, RN Levine, ... Journal of controlled release 349, 413-424, 2022 | 3 | 2022 |
| Natural Autoantibodies in Health and Disease P Lymberi, M Zannikou, A Hatzioannou Comprehensive Pharmacology, 342-368, 2022 | 3 | 2022 |
| Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain … D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ... Neuro-oncology advances 4 (1), vdac135, 2022 | 1 | 2022 |
| A New Mouse Model of Diffuse Midline Glioma to Test Targeted Immunotherapies M Seblani, M Zannikou, JT Duffy, RN Levine, Q Liu, CM Horbinski, ... bioRxiv, 2021.10. 15.464284, 2021 | 1 | 2021 |
| Interaction between DNA damage response, translation and apoptosome determines cancer susceptibility to TOP2 poisons CU Awah, L Chen, M Bansal, A Mahajan, J Winter, M Lad, L Warnke, ... bioRxiv, 614024, 2019 | 1 | 2019 |
